MedTrace Logo

Immuno Nutrition by L-citrulline for Critically Ill Patients

NCT02864017 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-06-09

No results posted yet for this study

Summary

The main objective of this study is to demonstrate that the only administration of L-citrulline, can improve immune functions in critically ill patients at high risk of nosocomial infection.

Conditions

  • Intubation
  • Pulmonary Ventilation

Interventions

PROCEDURE

Enteral nutrition

DIETARY_SUPPLEMENT

L-Citrulline

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Jean-Marc TADIE, MD · CHU Rennes

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2019-04-30
Completion
2020-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02864017 on ClinicalTrials.gov